The international humanitarian organization, Médecins sans Frontières, has called for a new mechanism for pooling reserves of Ebola vaccine for use in future outbreaks, and says that the price of Merck’s recently approved Ervebo vaccine must be “fair and reasonable.”
Ervebo was granted a conditional approval by the European Medicines Agency on 11 November, and was then quickly prequalified by...







